Valbiotis
Develops clinically proven, plant-based supplements for metabolic diseases.
ALVAL | PA
Overview
Corporate Details
- ISIN(s):
- FR0013254851
- LEI:
- 969500VP4JBJCF0MOP60
- Country:
- France
- Address:
- RUE PAUL VATINE, 17180 PERIGNY
- Website:
- https://www.valbiotis.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other food products
Description
Valbiotis is a research and development company that develops and commercializes plant-based dietary supplements for the prevention and management of metabolic diseases. The company's portfolio is centered on its patented "TOTUM" line of active substances, which undergo rigorous clinical trials to validate their efficacy. Key products include TOTUM•63 for reducing blood glucose in prediabetic individuals, TOTUM•448 for cardio-liver health, and TOTUM•854 for managing blood pressure. Valbiotis provides scientifically proven, natural, non-drug solutions and is transitioning from a research-focused model to a commercial-stage enterprise.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-04 08:00 |
Valbiotis annonce un accord avec Nestlé Health Science actant la fin du contrat…
|
French | 238.7 KB | ||
| 2024-06-04 08:00 |
Valbiotis reaches an agreement to terminate its licensing and supply agreement…
|
English | 217.5 KB | ||
| 2024-05-24 17:40 |
Valbiotis : Information mensuelle relative au nombre total de droits de vote e…
|
French | 111.8 KB | ||
| 2024-05-22 17:40 |
Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Chol…
|
English | 261.4 KB | ||
| 2024-05-22 17:40 |
Valbiotis lance son site de e-commerce pour la commercialisation de Valbiotis®…
|
French | 264.9 KB | ||
| 2024-05-14 08:30 |
Valbiotis : Information mensuelle relative au nombre total de droits de vote …
|
French | 111.6 KB | ||
| 2024-04-26 07:30 |
Valbiotis publishes its annual accounts 2023
|
English | 486.7 KB | ||
| 2024-04-26 07:30 |
Valbiotis publie ses comptes annuels 2023
|
French | 495.7 KB | ||
| 2024-04-08 17:40 |
Valbiotis : Information mensuelle relative au nombre total de droits de vote e…
|
French | 111.5 KB | ||
| 2024-04-03 08:30 |
Valbiotis to launch its 100% natural dietary supplement for the management of …
|
English | 479.2 KB | ||
| 2024-04-03 08:30 |
Valbiotis commercialisera dès mai sur le marché français son complément aliment…
|
French | 485.4 KB | ||
| 2024-03-07 17:40 |
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 108.8 KB | ||
| 2024-02-06 17:40 |
Valbiotis : Information mensuelle relative au nombre total de droits de vote e…
|
French | 109.3 KB | ||
| 2024-01-30 17:40 |
Valbiotis : Bilan du contrat de liquidité pour le deuxième semestre 2023
|
French | 1015.3 KB | ||
| 2024-01-29 17:40 |
Valbiotis presents its 2024 financial communication calendar
|
English | 484.2 KB |
Automate Your Workflow. Get a real-time feed of all Valbiotis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valbiotis
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valbiotis via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | N/A | Other | Other | 10,400 | 46,072.00 EUR |
Peer Companies
